Heart Valves, Transplants and Evaluating Treatments

Why heart valves matter

The heart works as a pump, and its valves keep blood moving in the correct direction. A healthy valve opens sufficiently when blood needs to pass through and then closes to prevent backflow. This one-way flow helps each heartbeat deliver an effective volume of blood.

A valve can become faulty in two main ways:

• it may not open fully, restricting the amount of blood that can pass through;
• it may not close properly, allowing some blood to leak backwards.

In either case, less blood may be moved forwards with each heartbeat. The heart may have to work harder to maintain the circulation, while body tissues may receive less oxygen. With less oxygen available for aerobic respiration, less energy is transferred for processes such as muscle contraction. A person may therefore become tired or short of breath, especially during activity.

Replacing a faulty valve

A severely faulty valve can be removed or bypassed and replaced by either a biological valve or a mechanical valve. Both aim to restore one-way blood flow, but they involve different compromises.

A mechanical valve is made from artificial materials. It is durable and can last a long time. However, blood clots may form around it, so the patient may need long-term anti-clotting medication. That medication lowers the risk of a dangerous clot but can increase the risk of bleeding.

A biological valve is made from animal or human tissue. Blood clots are less likely to form around it, so long-term anti-clotting medication may not be needed for the valve itself. However, biological valves are less durable and may eventually need replacing. Further surgery carries additional risks. The use of animal tissue may also raise ethical or religious concerns for some patients.

Neither choice is automatically best. Durability may be especially important for a younger patient, whereas avoiding long-term anti-clotting medicine may matter more for a patient at high risk of bleeding. Doctors and patients must balance these factors alongside the risks of surgery, such as infection and complications from anaesthesia.

When the whole heart is failing

Heart failure means that the heart cannot pump blood effectively enough to meet the body’s needs. If the damage is severe, repairing one valve or treating a narrowed artery may not solve the problem. A donor heart—or, in some cases, a donor heart and lungs—can then be transplanted.

A successful heart transplant can restore effective circulation and greatly improve quality of life and life expectancy. Unlike a mechanical device, the transplanted heart functions as a living organ.

There are important disadvantages. Suitable donor organs are scarce, so a patient may wait a long time and may become more unwell while waiting. The operation itself is major surgery. In addition, the recipient’s immune system can recognise cells in the donor heart as foreign and attack them. This is rejection.

The patient therefore takes immunosuppressant drugs. These reduce the immune response and make rejection less likely, but they also reduce the body’s ability to fight pathogens. This increases the risk of infectious disease. A transplant consequently requires continuing medication and medical monitoring rather than being a completely risk-free cure.

Artificial hearts as mechanical support

An artificial heart is a mechanical device that supports or replaces the heart’s pumping action. In this course, its main roles are to keep a patient alive while a suitable donor heart is found, or to allow the patient’s own heart to rest and possibly recover.

An artificial heart can be available without waiting for a human donor and is not rejected by the immune system. This can make it a vital option for a critically ill patient. However, fitting it requires surgery, with risks including infection. Contact between blood and the device may also encourage clot formation, and the device requires a power supply. Mechanical parts can wear out, so an artificial heart does not reproduce every advantage of a healthy living organ.

Comparing drugs, mechanical devices and transplants

Treatments should be matched to the problem rather than ranked in isolation.

The correct conclusion depends on the evidence in the question. Drugs may be appropriate when disease can be controlled without surgery. A replacement valve is more relevant when the problem is a particular faulty valve. For severe heart failure, transplantation may offer the greatest long-term improvement, but an artificial heart may be needed immediately while no donor is available. A strong evaluation weighs how effective each option is against its risks, availability and long-term demands.